PATENT CLAIM ANALYSIS

Application Number: 15897947
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "275000"]

Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid form or a salt form, such as a disodium salt form, can be used to treat or alleviate pain or related conditions, such as low back pain.

Claim (Index 7):
A method of treating low back pain, comprising: 1) fasting a human being for at least one hour, wherein the human being is suffering from low back pain, followed by 2) orally administering a dosage form comprising zoledronic acid in a disodium salt form to the human being, followed by 3) fasting the human being for at least one hour, wherein the zoledronic acid in the disodium salt form is administered in a manner that results in a bioavailability of zoledronic acid that is about 2% to 3%.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.53333
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15403073', '15697267', '15416995', '15439774', '15587108']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8513277313839855
- 35 USC 102 Novelty (BERT): 0.6167653399611611
- Combined Prediction Score: 0.8278714922417032
- Mean Citation Score: 648.307588
- Max Citation Score: 676.0469
- Similarity Product: 496.45175412430166

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test